Skip to content

Drug interactions

Alpelisib + Efavirenz

Severity: Moderate

Alpelisib and Efavirenz: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz may reduce alpelisib exposure by inducing CYP3A4, although alpelisib is metabolized mainly by non-CYP routes, so the effect is likely modest.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to see why Alpelisib and Efavirenz interact, what to do about it, and the sources.

  • Mechanism of action
  • Clinical management
  • Evidence level

Try Pro+ free for 14 days on the web. No card needed.

Drug class

Alpelisib
Oncology
Efavirenz
Anti Virals

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in